These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3574359)

  • 1. Resolution of acquired factor X deficiency and amyloidosis with melphalan and prednisone therapy.
    Camoriano JK; Greipp PR; Bayer GK; Bowie EJ
    N Engl J Med; 1987 Apr; 316(18):1133-5. PubMed ID: 3574359
    [No Abstract]   [Full Text] [Related]  

  • 2. Acquired factor X deficiency and amyloidosis treated with melphalan and prednisone.
    Levin M; Chokas W
    N Engl J Med; 1987 Oct; 317(18):1155-6. PubMed ID: 3657882
    [No Abstract]   [Full Text] [Related]  

  • 3. Resolution of acquired factor X deficiency with amyloidosis secondary to plasma cell dyscrasia.
    Mohri H
    Am J Hematol; 2004 Dec; 77(4):421-2. PubMed ID: 15551292
    [No Abstract]   [Full Text] [Related]  

  • 4. [Primary amyloidosis associated to severe factor X deficiency].
    Pérez Martínez J; Llamas F; López Montes A; Massó P; Poblet E; López Rubio E; Gallego E; Gómez Roldán C
    Nefrologia; 2004; 24(5):493-8. PubMed ID: 15648909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of systemic amyloidosis with hepatic involvement and factor X deficiency by high dose melphalan chemotherapy and autologous stem cell reinfusion.
    Breems DA; Sonneveld P; de Man RA; Leebeek FW
    Eur J Haematol; 2004 Mar; 72(3):181-5. PubMed ID: 14962236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired factor X and antithrombin III deficiency in a patient with primary amyloidosis and nephrotic syndrome.
    Quitt M; Aghai E; David M; Kohan R; Ben Ari Y; Froom P
    Scand J Haematol; 1985 Aug; 35(2):155-7. PubMed ID: 3876596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of hemorrhagic syndrome due to an acquired, combined deficiency of factors VII and X in a patient with multiple myeloma and amyloidosis.
    Elezović I; Djukanović R; Rolović Z
    Eur J Haematol; 1989 Jan; 42(1):105-6. PubMed ID: 2914589
    [No Abstract]   [Full Text] [Related]  

  • 8. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.
    Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M
    Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor recovery and short survival of infused factor X in a case of acquired factor X deficiency and amyloidosis.
    Duncan EM; Cole J; Clarkson AR; Lloyd JV
    Thromb Haemost; 1999 Oct; 82(4):1375-6. PubMed ID: 10544941
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acquired factor X deficiency in primary amyloidosis].
    Estivill X; Zurita L; Santesmasses A; Piera J; Segura J; Félez J
    Med Clin (Barc); 1984 Jun; 83(5):223. PubMed ID: 6482586
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acquired deficit in factor X associated with amyloidosis. One case (author's transl)].
    Maroy B; Mottier D; Saleun JP; Bergeret G
    Nouv Presse Med; 1978 Nov; 7(38):3441-2. PubMed ID: 740523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined deficiency of factor VII and X in a patient with multiple myeloma and amyloidosis].
    Elezović I; Rolović Z; Bukanović R; Bosković D; Milosević N; Marković J; Krasojević I; Blagojević R
    Srp Arh Celok Lek; 1987 Apr; 115(4):449-60. PubMed ID: 3270180
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolated factor X deficiency in amyloidosis. Case report and review of the literature.
    Van Dam FE; de Pauw BE; Schutjes CP; Veuger AJ
    Neth J Med; 1975; 18(4):129-34. PubMed ID: 1101084
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy of primary amyloidosis with melphalan and prednisone.
    Schwartz RS; Cohen JR; Schrier SL
    Arch Intern Med; 1979 Oct; 139(10):1144-7. PubMed ID: 485747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy options in systemic AL-amyloidosis with renal involvement].
    Hetzel GR; Schneider P; Mondry A; Heering P; Heyll A; Grabensee B
    Dtsch Med Wochenschr; 2000 Aug; 125(34-35):997-1002. PubMed ID: 11004911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine.
    Kyle RA; Gertz MA; Greipp PR; Witzig TE; Lust JA; Lacy MQ; Therneau TM
    N Engl J Med; 1997 Apr; 336(17):1202-7. PubMed ID: 9110907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The successful treatment of primary amyloidosis with intermittent chemotherapy.
    Bradstock K; Clancy R; Uther J; Basten A; Richards J
    Aust N Z J Med; 1978 Apr; 8(2):176-9. PubMed ID: 277166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary systemic amyloidosis. Comparison of melphalan/prednisone versus colchicine.
    Kyle RA; Greipp PR; Garton JP; Gertz MA
    Am J Med; 1985 Dec; 79(6):708-16. PubMed ID: 3934968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A patient with AL amyloidosis and severe factor X deficiency has been in complete haematological remission with normal factor X activity for 7 years following high-dose chemotherapy. A case study and literature review].
    Adam Z; Matýková M; Krejcí M; Pour L; Kissová J; Slechtová M; Chlupová G; Stavarová Y; Simonides J; Penka M; Mayer J; Hájek R
    Vnitr Lek; 2010 Jan; 56(1):67-78. PubMed ID: 20184115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Follicular mucinosis with generalized para-amyloidosis as a cutaneous paraneoplastic syndrome in myeloma (IgD and light chain plasmacytoma). A demonstration of the course using melphalan-prednisone therapy with a 3 years remission].
    Jänner M; Lippert HD; Stolzenbach G
    Z Hautkr; 1977 Aug; 52(16):873-40. PubMed ID: 408988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.